F. Poulain et al. / Tetrahedron Letters 50 (2009) 1803–1805
1805
Germany, 2003; pp 381–406; (b) Danishefsky, S. J.; Allen, J. R. Angew. Chem., Int.
Ed. 2000, 39, 836–863.
2. Seitz, O. ChemBioChem. 2000, 1, 214–246.
3. Schofield, L.; Hewitt, M. C.; Evans, K.; Siomos, M. A.; Seeberger, P. H. Nature
2002, 418, 785–789.
4. Zachara, N. E.; Hart, G. W. Chem. Rev. 2002, 102, 431–438.
5. Islam, T.; Linhardt, R. J. Chemistry, Biochemistry, and Pharmaceutical Potentials
of Glycosaminoglycans and Related Saccharides. In Carbohydrate-Based Drug
Discovery; Wong, C.-H., Ed.; Wiley-VCH: Weinheim, Germany, 2003; Vol. 1, pp
407–439.
the most reasonable pathway since, as explained above, a steric
discrimination is more likely under these conditions than the
H-bonding approach.
A second strategy was developed which is based on the Over-
man sigmatropic [3,3]-rearrangement of a trichloroacetimidate de-
rived from 4. This reaction has been quite developed for the
synthesis of classical 2-deoxy-2-amino-D
-glycosides.14 Trichloro-
acetimidate 10 was thus prepared using standard conditions, and
several attempts were made to promote the sigmatropic rear-
rangement (Scheme 3). It was already known from previous
reports that compounds with the glucose configuration required
higher temperatures than their galactose counterparts for the rear-
rangement to occur. For stereoelectronic reasons, a pseudo-axial
arrangement of the trichloroacetimidate moiety in the transition
state is indeed necessary for this reaction. In the glucose series, this
can be achieved only by reaching a pseudo-chair conformation of
higher-energy (Scheme 3). High temperatures are thus required
and the best results were obtained in refluxing 1,2-dichloroben-
zene with a catalytic amount of potassium carbonate, yielding
trichloroacetamide 11 in 32% yield (Scheme 3).15
6. (a) Karche, N. P.; Pierry, C.; Poulain, F.; Oulyadi, H.; Leclerc, E.; Pannecoucke, X.;
Quirion, J.-C. Synlett 2007, 123–126; (b) Moreno, B.; Quehen, C.; Rose-Hélène,
M.; Leclerc, E.; Quirion, J.-C. Org. Lett. 2007, 9, 2477–2480; (c) Poulain, F.; Serre,
A.-L.; Lalot, J.; Leclerc, E.; Quirion, J.-C. J. Org. Chem. 2008, 73, 2435–2438.
7. For other CF2-glycoside syntheses, see: (a) Houlton, J. S.; Motherwell, W. B.;
Ross, B. C.; Tozer, M. J.; Williams, D. J.; Slawin, A. M. Z. Tetrahedron 1993, 49,
8087–8106; (b) Herpin, T. F.; Motherwell, W. B.; Weibel, J.-M. Chem. Commun.
1997, 923–924; (c) Brigaud, T.; Lefebvre, O.; Plantier-Royon, R.; Portella, C.
Tetrahedron Lett. 1996, 37, 6115–6116; (d) Berber, H.; Brigaud, T.; Lefebvre, O.;
Plantier-Royon, R.; Portella, C. Chem. Eur. J. 2001, 7, 903–909; (e) Wegert, A.;
Miethchen, R.; Hein, M.; Reinke, H. Synthesis 2005, 1850–1858; (f) Wegert, A.;
Hein, M.; Reinke, H.; Hoffmann, N.; Miethchen, R. Carbohydr. Res. 2006, 341,
2641–2652; (g) Hirai, G.; Watanabe, T.; Yamaguchi, K.; Miyagi, T.; Sodeoka, M.
J. Am. Chem. Soc. 2007, 129, 15420–15421; (h) Tony, K. A.; Denton, R. W.; Dilhas,
A.; Jiménez-Barbero, J.; Mootoo, D. R. Org. Lett. 2007, 9, 1441–1444; (i) Denton,
R. W.; Tony, K. A.; Hernandez-Gay, J. J.; Canada, F. J.; Jimenez-Barbero, J.;
Mootoo, D. R. Carbohyd. Res. 2007, 342, 1624–1635.
The next step was thus to functionalize the remaining double
bond in order to access to the desired 2-amino-CF2-glycoside.
The dihydroxylation of related compounds was well documented
and was expected to occur anti to the trichloroacetamide group
8. (a) Mello, R.; Fiorentino, M.; Sciacovelli, 0.; Curci, R. J. Org. Chem. 1988, 53, 3890–
3891; (b) Adam, W.; Curci, R.; Edwards, J. O. Acc. Chem. Res. 1989, 22, 205–211; (c)
Yang, D.; Wong, M.-K.; Yip, Y.-C. J. Org. Chem. 1995, 60, 3887–3889.
9. To a solution of b-4 (245 mg, 0.50 mmol) in acetonitrile (8 mL) cooled at 0 °C
were added a solution of EDTA (0.0004 M in water, 4 mL) and trifluoroacetone
to deliver preferentially the 2-deoxy-2-amino-D-galactose ana-
(3.5 mmol).
A mixture of NaHCO3 (0.8 g, 9.5 mmol) and oxone (1.8 g,
logue.14b,c To our disappointment, compound 11 remained totally
unreactive under all the conditions which were tested (cat. OsO4/
NMO or stoichiometric OsO4 in different solvent systems, at room
temperature or at 60 °C). This lack of reactivity of the double bond
was attributed to the combined strong electron-withdrawing ef-
fects of the trichloroacetamide group and, to a lesser extent, of
the difluoroacetate group. Unfortunately, our attempts to depro-
tect the trichloroacetamide moiety affected also the highly reactive
difluoroacetate and raised many compatibility problems. The
epoxidation reaction of 11 was not examined but the synthesis
of the desired 2-deoxy-2-amino-CF2-glycoside would anyway in-
volve a difficult opening of the resulting epoxide with oxygen
nucleophiles. Combined with the low yield obtained for the rear-
rangement, this approach was thus too compromised to be further
investigated.
2.93 mmol) was added at 0 °C in small portions over 4 h. The slurry was
vigorously stirred at 0 °C until complete consumption of the starting material,
and then concentrated under reduced pressure to remove acetonitrile. The
concentrate was dissolved in a minimal amount of water and AcOEt (10 mL).
The aqueous layer was extracted with AcOEt (2 Â 10 mL). The organic layers
were combined and washed with brine (15 mL), dried over magnesium sulfate
and concentrated under reduced pressure. Purification by column
chromatography over silica gel (cyclohexane/AcOEt 85:15) afforded 7 as a
colourless oil (220 mg, 86% yield): Rf = 0.30 (cyclohexane/AcOEt 8:2); [a]
D
+1.59 (c 0.39, CHCl3); 1H NMR (300 MHz; CDCl3) d 7.68–7.62 (m, 4H), 7.49–7.36
(m, 6H), 4.38–4.20 (m, 3H), 4.15–4.08 (m, 1H), 3.87–3.77 (m, 2H), 3.76 (d,
J = 4.1 Hz, 1H), 3.59 (dd, J = 4.1 Hz, J = 1.3 Hz, 1H), 3.50–3.45 (m, 1H), 2.58 (d,
J = 6.4 Hz, 1H), 1.26 (t, J = 7.2 Hz, 3H), 1.04 (s, 9H); 19F NMR (282.5 MHz; CDCl3)
d À113.3 (dd, J = 271.5 Hz, J = 7.5 Hz, 1F), À120.3 (dd, J = 271.5 Hz, J = 14.0 Hz,
1F); 13C NMR (75.5 MHz; CDCl3) d 135.9, 130.3, 128.2, 112.9 (t, J = 254.7 Hz),
74.2, 73.8 (t, J = 28.8 Hz), 66.8, 64.3, 60.9, 54.5 (2C), 27.0, 14.5; IR (neat) mmax
3436.1, 2930.8, 2857, 1762.2 cmÀ1; MS (ESI+) m/z = 529 ([M+Na]+); Anal. Calcd
for C26H32F2O6Si: C, 61.64; H, 6.37. Found: C, 61.59; H, 6.43.
10. To a solution of 7 (130 mg, 0.26 mmol) in dichloromethane (3 mL) cooled at
À30 °C were added TMSN3 (0.8 mL, 6 mmol) and BF3ÁEt2O (36
lL, 0.28 mmol).
In conclusion, we applied our recently developed difluoroenox-
ysilane addition reaction to the synthesis of 2-deoxy-2-aminogly-
The solution was allowed to warm up to 10 °C over 4 h. After complete
conversion of the starting material (TLC monitoring), a saturated aqueous
solution of NaHCO3 (5 mL) was added and the mixture was extracted with
AcOEt (3 Â 5 mL). The combined organic extracts were washed with brine
(8 mL), dried over magnesium sulfate and concentrated under reduced
pressure. Purification by column chromatography over silica gel
coside analogues.
A CF2-analogue of 2-deoxy-2-acetamido-D-
altrose, first example of a CF2-aminopyranoside, has been synthe-
sized through an epoxidation/azidation sequence performed on
the addition product b-4. Another approach, based on the Overman
(cyclohexane/ethyl acetate 80:20, 1% triethylamine) afforded
8 as a
colourless oil (73 mg, 0.135 mmol, 52% yield): Rf = 0.20 (cyclohexane/AcOEt
rearrangement of the trichloroacetimidate derived from
a-4, was
8:2); [
a
]
D À8.25 (c 0.80, CHCl3); 1H NMR (300 MHz; CDCl3) d 7.68–7.63 (m, 4H),
also investigated. The expected product 11 was obtained but
unfortunately could not be converted to the corresponding
CF2-aminopyranoside using a dihydroxylation reaction. However,
these strategies remain reasonable approaches for the synthesis
of the CF2-analogues of these valuable carbohydrate derivatives.
Our efforts will now focus on the preparation of surrogates to
2-deoxy-2-aminoglycosides of biological importance, such as
7.50–7.38 (m, 6H), 4.38 (br s, 1H), 4.28 (dd, J = 2.7 Hz, J = 8.3, 1H), 4.22 (br s,
1H), 4.02–3.95 (m, 2H), 3.88 (s, 1H), 3.82–3.75 (m, 4H), 2.78 (d, J = 1.3 Hz, 1H),
1.12 (t, J = 7.2 Hz, 3H), 1.09 (s, 9H); 19F NMR (282.5 MHz; CDCl3) d À114.52
(ddd, J = 245.7 Hz, J = 7.5 Hz, J = 2.1 Hz, 1F), -130.34 (d, J = 245.7 Hz, 1F); 13C
NMR (75.5 MHz; CDCl3) d 135.7, 132.2, 130.3, 128.1, 120.9 (t, J = 250.1 Hz),
77.6, 72.7 (dd, J = 17.7 Hz, J = 36.6 Hz), 70.7, 69.1, 66.8, 66.3, 60.1, 26.9, 19.2,
15.2; IR (neat) mmax 3448.2, 2931.6, 2858.5, 2130.9, 1762 cmÀ1; MS (IC+) m/
z = 567 ([M+NH4]+); Anal. Calcd for C26H33F2N3O6Si: C, 56.82; H, 6.05; N, 7.64.
Found: C, 56.86; H, 6.05; N, 7.58.
11. H-2 and H-3 appear as broad singlets on the 1H NMR spectrum, indicating the
absence of large diaxial coupling constants and thus that these protons are in
equatorial position (see Ref. 10).
a-GalNAc and b-GlcNAc.
Acknowledgements
12. Rickborn, B. Acid-catalyzed Rearrangements of Epoxides. In Comprehensive
Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: New York, USA,
1991; Vol. 3, pp 733–775.
13. Murray, R. W.; Singh, M.; Williams, B. L.; Moncrieff, H. M. J. Org. Chem. 1996, 61,
1830–1841.
We thank Perigene Inc. for a PhD grant to F.P. and the Associa-
tion pour la Recherche contre le Cancer for financial support.
14. (a) Dyong, I.; Weigand, J.; Merten, H. Tetrahedron Lett. 1981, 22, 2965–2968; (b)
Takeda, K.; Kaji, E.; Konda, Y.; Sato, N.; Nakamura, H.; Miya, N.; Morizane, A.;
Yanagisawa, Y.; Akiyama, A.; Zen, S.; Harigaya, Y. Tetrahedron Lett. 1992, 33,
7145–7148; (c) Donohoe, T. J.; Blades, K.; Helliwell, M. Chem. Commun. 1999,
1733–1734.
References and notes
1. (a) Keding, S. J.; Danishefsky, S. J. Synthetic Carbohydrate Vaccines. In
Carbohydrate-Based Drug Discovery; Wong, C.-H., Ed.; Wiley-VCH: Weinheim,
15. Nishikawa, T.; Asai, M.; Ohyabu, N.; Isobe, M. J. Org. Chem. 1998, 63, 188–192.